FDA advisory panel to vote on COVID-19 vaccine strains for 2025-2026 campaign amid uncertainty over dominant variants.

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

New studies stemming from the Armamentarium consortium outline findings that advance tools based on Adeno-associated virus ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate ...

The new giants of Wall Street are breaking down old boundaries ...

FDA Commissioner Marty Makary was met with a skeptical set of Senate appropriators Thursday when he testified on his agency’s ...

Authorities are investigating after several people came down with symptoms of norovirus, the highly-contagious, ...

Large language models (LLMs) applications range from text processing to predicting virus variants. As the datasets on which ...

Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate vaccines and public health systems brace for another season of jabs and logistics.

Investors target stocks that have been on a bullish run lately. Stocks like DB, HRTG, PAHC and TGI are seeing price strength ...

The Food and Drug Administration (FDA) vaccine advisory group today recommended sticking with a monovalent JN.1 lineage ...